Bilateral pseudoangiomatous stromal hyperplasia in a human immunodeficiency viral-infected patient.

Pseudoangiomatous stromal hyperplasia (PASH) is an uncommon mesenchymal neoplasm of the breast demonstrating stromal myofi broblastic proliferation and having the appearance of anastomosing slit-like pseudovascular spaces lined by spindle-shaped cells. A case of nodular PASH of the bilateral breasts in a 40-year-old woman with clinically presenting with a progressive enlarged breast lump is reported. Mammographic and ultrasonographic features of the right and left breasts showed a large solid lump with well-circumscribed border measuring 4 cm  1.7 cm  3.4 cm and 13.8 cm  10.9 cm  12.1 cm, respectively. Wide excision of the right breast and quadrantectomy of the left breast were performed. The histopathological examination of the lesion showed anastomosing slit-like pseudovascular spaces. The stromal cells were immunoreactive for muscle actin (HHF35), smooth muscle actin, and progesterone receptor. Clinical and pathological fi ndings with briefl y reviewed relevant literatures are discussed. This is the fi rst clinicopathological and radiological report of bilateral mammary nodular PASH in a human immunodefi ciency viral-infected patient.

Breast pain and service satisfaction during digital mammography.

OBJECTIVES: To determine the frequency and predisposing factors of breast pain felt during digital mammography, and factors associated with service satisfaction. MATERIAL AND METHOD: A questionnaire was distributed to 1250 women immediately after their mammography. The outcomes assessed were a five-point scale of breast pain and rating of the satisfaction with the mammography service. Several factors potentially associated with breast pain and satisfaction were obtained from the questionnaire and analyzed. Multiple cumulative logit regression was used to identify independent, significant factors. RESULTS: Breast pain was found to be absent in 22% of patients, slight in 50%, moderate in 23% and substantial or severe in only 4%. Significant factors associated with breast pain during mammography included higher educational level, having no children, having had prior mammography, impolite and rough radiographer and poorly performed mammography. Factors associated with satisfaction with the mammography service included older age, polite and gentle radiographer and well-performed mammography. CONCLUSION: Radiographer delivery of the mammography service seemed to be the most important, modifiable reason for breast pain during mammography and dissatisfaction with the mammography service.

Positive predictive value of breast cancer in the lesions categorized as BI-RADS category 5.

OBJECTIVE: To determine positive predictive value (PPV) of the breast imaging reporting and data systems (BI-RADS) category 5 mammogram and ultrasound (US) in the diagnosis of breast cancer in the study center and correlation between clinical, mammographic and US findings, and breast cancer. MATERIAL AND METHOD: Four hundred and ninety seven patients with BI-RADS category 5 who underwent mammograms and US at the Breast diagnostic center, Ramathibodi Hospital from January, 1, 2002 to December 31, 2004 were enrolled into the present study. Selected clinical information, mammographic and US findings, and histopathological diagnosis were retrospectively reviewed. RESULTS: Breast cancer was found in 467 of 497 patients, giving a PPV of 94%. Invasive ductal carcinoma was the most common malignancy (89.5%). Fibrocystic change was the most common benign pathology found in the remaining patients. Discrete mass was the most frequently encountered lesion detected on mammography and US, followed by mass containing calcifications. Patients with advanced age, having a clinically palpable breast mass, with mammographic and US evidence of mass containing calcifications showed significant statistical association with breast cancer. CONCLUSION: PPV of BI-RADS category 5 lesions in the present study was comparable to other published studies. Although the probability of malignancy was very high, a small number of patients had benign pathologies. Preoperative histopathologic diagnosis is necessary before definitive treatment.

Breast cancer in patients initially assigned as BI-RADS category 3.

OBJECTIVES: To determine the Positive Predictive Value (PPV) for malignancy and characteristics of breast cancer found in patients who were initially categorized as having Breast Imaging Reporting and Data System (BI-RADS) 3. MATERIAL AND METHOD: Medical records of patients assigned to BI-RADS 3 from January, 1st to December; 31st 2002 at the Breast diagnostic center, Ramathibodi Hospital who had imaging follow-up for at least 2 years or had biopsy performed were retrospectively reviewed RESULTS: Of 949 patients, 23 were found to have malignancy, i.e., 2.4% PPV. The most common imaging findings of breast cancer were calcifications on mammogram and mass on sonogram. Mean interval from first imaging to biopsy was 13.1 months. Only 78% of malignancies were diagnosed within 2 years. Less than 50% of these were ductal carcinoma in situ or stage I invasive ductal carcinoma. CONCLUSION: PPV for malignancy in the present study was comparable to the previous studies. However, longer time to diagnosis and more advanced stage of breast cancer at diagnosis were found Periodically short-interval mammogram and sonogram, at not less than 2 year-intervals, were recommended

Breast cancer underestimation rate of atypical ductal hyperplasia diagnosed by core-needle biopsy under imaging guidance.

OBJECTIVE: To evaluate breast cancer underestimation rate of atypical ductal hyperplasia (ADH) diagnosed by core-needle biopsy (CNB) under imaging guidance in Ramathibodi Hospital and to determine the difference between the malignant and benign groups in terms of clinical and imaging characteristics. MATERIAL AND METHOD: The pathological records of 1521 patients who underwent CNB under imaging guidance were reviewed. Thirty-nine patients diagnosed with ADH were enrolled into the present study. Clinical data, imaging features, biopsy technique and result of excisional biopsy as well as follow-up data were retrospectively reviewed. RESULTS: Of 39 ADH cases, eight (20.5%) were found to have malignancy on subsequent excisional biopsy. The majority of these were ductal carcinoma in situ (DCIS) (62.5%). Lesion categorized as category 5 according to BI-RADS (Breast imaging reporting and data system) was the only feature which was statistically different between the benign and malignant groups. No statistically significant difference was found between the benign and malignant groups in terms of age, personal and family history of breast cancer, clinical finding, mammographic lesion type, size of lesion, image-guided technique and percentage of lesion removal. CONCLUSION: The underestimation rate of ADH in the present study was comparable to other studies. The finding of Bl-RADS category 5 in patients with ADH diagnosed from CNB is a strong indication for subsequent excisional biopsy.

Nondiagnostic core needle biopsy of the breast under imaging guidance: result of rebiopsy.

OBJECTIVE: To determine the rate and the clinical application of recommendation for repeat biopsy after core needle biopsy (CNB) under imaging guidance and to determine the result of rebiopsy. MATERIAL AND METHOD: A retrospective review was performed in 1,306 consecutive women who underwent core needle biopsy under imaging guidance at the breast diagnostic center, the Faculty of Medicine, Ramathibodi Hospital from October 1997 to March 2004. RESULTS: Among 1,306 patients, there were 44 patients (3.37%) who had undergone rebiopsy. The three most common reasons for recommendation of rebiopsy were discordant imaging and pathology, atypical ductal hyperplasia and inadequate specimen. The authors found 12 malignancies subsequently found in rebiopsy (27.3%). The most common reason for rebiopsy in this group was inadequate specimen. CONCLUSION: Core needle biopsy under imaging guidance is a minimally invasive diagnostic tool and promises high accuracy and reliability. However, some patients need rebiopsy to exclude hidden malignancy. The cooperation between the radiologists, surgeons and pathologists are prudent for giving the best care to the patients.